An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism

被引：126
|
作者：
Giannotti, F.
Cortesi, F.
Cerquiglini, A.
Bernabei, P.
机构：
[1] Univ Roma La Sapienza, Dept Dev Neurol & Psychiat, Ctr Pediat Sleep Disorders, I-00185 Rome, Italy
[2] Univ Roma La Sapienza, Dept Dev Neurol & Psychiat, PDD Clin, I-00185 Rome, Italy
来源：
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2006年 / 36卷 / 06期
关键词：
sleep disorders; autism; melatonin treatment; long-term study;
D O I：
10.1007/s10803-006-0116-z
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
Long-term effectiveness of controlled-release melatonin in 25 children, aged 2.6-9.6 years with autism without other coexistent pathologies was evaluated openly. Sleep patterns were studied using Children's Sleep Habits Questionnaire (CSHQ) and sleep diaries at baseline, after 1-3-6 months melatonin treatment and 1 month after discontinuation. Sleep diary and CSHQ showed a more problematic sleep in autistic children compared with controls. During treatment sleep patterns of all children improved. After discontinuation 16 children returned to pre-treatment score, readministration of melatonin was again effective. Treatment gains were maintained at 12 and 24-month follow-ups. No adverse side effects were reported. In conclusion, controlled-release melatonin may provide an effective and well-tolerated treatment for autistic children with chronic sleep disorders.
引用
收藏
页码：741 / 752
页数：12
相关论文
共 50 条
  • [1] An Open-Label Study of Controlled-Release Melatonin in Treatment of Sleep Disorders in Children with Autism
    F. Giannotti
    F. Cortesi
    A. Cerquiglini
    P. Bernabei
    Journal of Autism and Developmental Disorders, 2006, 36 : 741 - 752
  • [2] Melatonin in the treatment of chronic sleep disorders in adults with autism: a retrospective study
    Galli-Carminati, Giuliana
    Deriaz, Nicolas
    Bertschy, Gilles
    SWISS MEDICAL WEEKLY, 2009, 139 (19-20) : 293 - 296
  • [3] An open-label trial of risperidone in children with autism
    Diler, RS
    Firat, S
    Avci, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (01): : 91 - 102
  • [4] Bumetanide for autism: Open-label trial in six children
    Fernell, Elisabeth
    Gustafsson, Peik
    Gillberg, Christopher
    ACTA PAEDIATRICA, 2021, 110 (05) : 1548 - 1553
  • [5] The role of probiotics in children with autism spectrum disorder: A prospective, open-label study
    Shaaban, Sanaa Y.
    El Gendy, Yasmin G.
    Mehanna, Nayra S.
    El-Senousy, Waled M.
    El-Feki, Howaida S. A.
    Saad, Khaled
    El-Asheer, Osama M.
    NUTRITIONAL NEUROSCIENCE, 2018, 21 (09) : 676 - 681
  • [6] Open-label observational study of the homeopathic medicine Passiflora Compose for anxiety and sleep disorders
    Villet, Stephanie
    Vacher, Veronique
    Colas, Aurelie
    Danno, Karine
    Masson, Jean-Louis
    Marijnen, Philippe
    Bordet, Marie-France
    HOMEOPATHY, 2016, 105 (01) : 84 - 91
  • [7] Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study
    Cindy K. Schneider
    Raun D. Melmed
    Leon E. Barstow
    F. Javier Enriquez
    James Ranger-Moore
    James A. Ostrem
    Journal of Autism and Developmental Disorders, 2006, 36 : 1053 - 1064
  • [8] Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study
    Schneider, Cindy K.
    Melmed, Raun D.
    Enriquez, F. Javier
    Barstow, Leon E.
    Ranger-Moore, James
    Ostrem, James A.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2006, 36 (08) : 1053 - 1064
  • [9] Levetiracetam in autistic children: An open-label study
    Rugino, TA
    Samsock, TC
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2002, 23 (04) : 225 - 230
  • [10] Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study
    Andrés Martin
    Kathleen Koenig
    George M. Anderson
    Lawrence Scahill
    Journal of Autism and Developmental Disorders, 2003, 33 : 77 - 85
12345